SEC Filing Analysis: Applied Therapeutics, Inc.

Executive Summary

• Trading Significance: Medium
• Key Takeaway: Alexandria Real Estate Equities, Inc., a significant institutional investor, has reduced its beneficial ownership in Applied Therapeutics to 4.3%, falling below the 5% reporting threshold.
• Market Impact: This signals a reduction in stake from a major backer, which can be viewed as a neutral to slightly negative indicator by the market. The position remains substantial but no longer requires activist-level reporting.

Company Information

Field	Value
Company	Applied Therapeutics, Inc.
Ticker Symbol	APLT (Inferred)
CIK	0001697532
Industry	PHARMACEUTICAL PREPARATIONS

Reporting Entity Information

Field	Value
Name	Alexandria Real Estate Equities, Inc.
CIK	0001035443
Title/Position	Corporation
Relationship	Beneficial Owner

Transaction Details

Field	Value
Form Type	SCHEDULE 13G/A
Event Date	2025-12-11
Transaction Code	Not Applicable
Security Type	Common Stock and Warrants
Shares Involved	Not Applicable (Status Change)
Price Per Share	Not Applicable
Total Value	Not Applicable
Shares Owned After	6,500,000 (via exercisable warrants)
Ownership Type	Indirect

Financial Impact Assessment

Transaction Materiality

Note: Market capitalization data for the subject company, Applied Therapeutics, Inc., was not provided. Analysis is based on shares outstanding as disclosed in the filing.

Metric	Value
Shares Beneficially Owned	6,500,000
Subject Co. Shares Outstanding	144,300,674 (as of 11/12/2025)
Post-Event Ownership %	4.3%
Materiality Assessment	Medium

Impact Evaluation

• Ownership Concentration: Alexandria's position, held entirely through exercisable warrants by its subsidiaries, has decreased from over 5% to 4.3%. While still a large stake, crossing below the 5% threshold is a significant event that reduces their reporting obligations.
• Transaction Significance: The primary significance is not a single large trade but the change in status. Dropping below 5% beneficial ownership means the entity is no longer considered a major insider for reporting purposes, which can be interpreted as a step towards further liquidation or simply a portfolio rebalancing.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: While a reduction in stake by a notable investor can be a negative signal, this is not a full exit. The filing simply documents that the ownership has fallen below a key reporting level. Market reaction is likely to be muted unless it's part of a larger pattern of institutional selling.

Volume & Sentiment

• Expected Volume Impact: Low. This filing reports a change in status rather than a recent, large open-market transaction that would directly impact trading volume.
• Sentiment Indicator: Neutral. The filing confirms a reduction in conviction from a large holder but does not necessarily signal an impending collapse or a complete loss of faith in the company's prospects.

Investment Insights

Risk Factors

• A sophisticated venture investor is reducing its reportable position.
• The ownership is via warrants, which have different characteristics and risk profiles than common stock.

Key Takeaways

1. Status Change is Key: The main news is Alexandria Real Estate Equities dropping below the 5% beneficial ownership threshold in Applied Therapeutics.
2. Substantial Holding Remains: Despite the percentage drop, a 4.3% stake representing 6.5 million potential shares is still a significant position.
3. Passive Filing: The filing was made under Rule 13d-1(c), certifying the shares were not acquired or held for the purpose of changing or influencing control of the issuer.